Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
09/2005
09/14/2005EP1574856A1 Method of screening cell growth inhibitor and cell growth inhibitor
09/14/2005EP1574578A1 Monomeric protein of the TGF-beta family
09/14/2005EP1574577A2 Growth differentiation factor-11
09/14/2005EP1574575A1 GLUCOSE AND/OR FRUCTOSE TRANSPORTER NaGLT1 AND ITS GENE
09/14/2005EP1574574A1 Exon 1-beta of pdgf receptor alpha gene and utilization thereof
09/14/2005EP1574569A1 Three-dimensional structure of lipocalin-type prostaglandin d synthase and utilization of the same
09/14/2005EP1574506A1 Remedies
09/14/2005EP1574219A2 Method of inhibiting fibrosis with a somatostatin agonist
09/14/2005EP1574215A1 Solid drug for oral use
09/14/2005EP1574212A1 Prevention and treatment of androgen-deprivation induced hot flashes, decreased lean muscle mass, loss of libido or erectile dysfunction
09/14/2005EP1573028A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
09/14/2005EP1573025A2 Crystallized structure of type iv collagen nc1 domain hexamer
09/14/2005EP1573003A2 Method for producing transgenic animals using oral gene therapy
09/14/2005EP1572995A2 Novel proteins and nucleic acids encoding same
09/14/2005EP1572939A2 Her-2 receptor tyrosine kinase molecules and uses thereof
09/14/2005EP1572892A2 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
09/14/2005EP1572890A2 Slc7s as modifies of the p53 pathway and methods of use
09/14/2005EP1572885A2 Methods for treating diabetes and other blood sugar disorders
09/14/2005EP1572881A2 Tacis and br3 polypeptides and uses thereof
09/14/2005EP1572877A2 Drug metabolizing enzymes
09/14/2005EP1572874A2 Antibodies that immunospecifically bind to trail receptors
09/14/2005EP1572872A2 Igs as modifiers of the p53 pathway and methods of use
09/14/2005EP1572864A2 Human serpin polypeptides
09/14/2005EP1572863A2 Method for identifying inhibitors of g protein coupled receptor signaling
09/14/2005EP1572719A2 Partial peptide mimetics and methods
09/14/2005EP1572665A2 1-n-phenylamino-1h-imidazole derivatives as aromatase inhibitors
09/14/2005EP1572655A2 Novel arylheteroalkylamine derivatives
09/14/2005EP1572646A1 N-(indolethyl-)cacloamine compounds
09/14/2005EP1572243A1 Induction of tolerance through oral administration of a therapeutic agent coupled to a transporting agent
09/14/2005EP1572188A1 Pregabalin derivatives for the treatment of fibromyalgia and other disorders
09/14/2005EP1572187A1 Pregabalin and derivatives thereof for the treatment of fibromyalgia and other related disorders
09/14/2005EP1572184A1 Gabapentin analogues for fibromyalgia and other related disorders
09/14/2005EP1572168A2 Anti-infarction molecules
09/14/2005EP1572165A1 New film coating
09/14/2005EP1572151A1 Liquid dosage forms of proton pump inhibitors
09/14/2005EP1572125A2 Compositions and methods for treating tumors bearing hmfg and cea antigens
09/14/2005EP1572077A2 Uses of monoclonal antibody 8h9
09/14/2005EP1572076A2 Helical peptidomimetics
09/14/2005EP1572073A2 Alteration of rab38 function to modulate mammalian pigmentation
09/14/2005EP1572072A2 Methods of treating infection by drug resistant bacteria
09/14/2005EP1572068A2 Arylheteroalkalylamine derivatives and their use as inhibitors of nitric oxide synthase
09/14/2005EP1572067A2 Conjugates and compositions for cellular delivery
09/14/2005EP1529048A4 Methods for the synthesis of substituted purines
09/14/2005EP1461318B1 Tetrahydroquinoline analogues as muscarinic agonists
09/14/2005EP1399157B1 Combination comprising a p-gp inhibitor and an anti-epileptic drug
09/14/2005EP1392643B1 Trisubstituted-n- (1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors
09/14/2005EP1390062A4 Modulators of elastase inhibitor secretion
09/14/2005EP1341781B1 Antimicrobial quinolones
09/14/2005EP1296700B1 Anti-carcinogenic activity of hydroxylated chalcone compounds extracted from licorice root
09/14/2005EP1284958B1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoidane derivatives
09/14/2005EP1283825B1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
09/14/2005EP1210335B1 Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments
09/14/2005EP1200402B1 Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain
09/14/2005EP1171127B1 Pharmaceutical compositions containing pyridine or pyrimidine derivatives for inhibition of cytokine production and secretion
09/14/2005EP1091737B1 Use of 1-(3,3-diphenylpropionyl)-4-benzhydril piperazine in the treatment of pain
09/14/2005EP1073418A4 Aqueous composition comprising active ingredients for the de-pigmentation of the skin
09/14/2005EP0981343B1 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
09/14/2005EP0970081B1 Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9h-purin-8-yl)phenyl derivatives, their preparation and their use in the treatment of inflammatory conditions and immune disorders
09/14/2005EP0804437B1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USES THEREOF
09/14/2005CN1668762A Sgk and Nedd used as diagnostic and therapeutic targets
09/14/2005CN1668759A Method of searching substane having antidiabetic activity
09/14/2005CN1668733A Methods of using JNK or MKK inhibitors to modulate cell differentiation and to treat myeloproliferative disorders and myelodysplastic syndromes
09/14/2005CN1668644A Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer
09/14/2005CN1668643A Method for using glucan-haemoglobin conjugale as blood substitute
09/14/2005CN1668630A Novel isoforms of vascular endothelial cell growth inhibitor
09/14/2005CN1668623A Pseudopolymorphic forms of a HIV protease inhibitor
09/14/2005CN1668622A 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
09/14/2005CN1668620A 1-heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands
09/14/2005CN1668619A Imidazo[1, 2-a]pyrazin-8-ylamines, method of making and method of use thereof
09/14/2005CN1668609A Substituted 4-aryl-4H-pyrrolo[2, 3-H]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
09/14/2005CN1668606A Oxazole derivatives and their use as insulin sensitizers
09/14/2005CN1668605A Broadspectrum substituted benzisoxazole sulfonamide HIV protease inhibitors
09/14/2005CN1668603A Pyridazin-3(2h)-one derivatives as PDE4 inhibitors
09/14/2005CN1668600A 5-substituted isoquinoline derivatives
09/14/2005CN1668594A New derivatives of pyridilethanol (phenylethyl) amines as cholesterol biosynthesis inhibitors, procedures of their preparation and pharmaceutical preparations which they contain
09/14/2005CN1668592A Piperidine derivatives and their use as selective inhibitors of MIP-1alpha binding to its receptor CCR1
09/14/2005CN1668590A 1-heterocyclylalkyl-3-sulfonyl-indole or -indazole derivatives as 5-hydroxytryptamine-6 ligands
09/14/2005CN1668589A Indoline derivatives substituted in the 6 position, their preparation and their use as medicaments
09/14/2005CN1668588A Indole derivatives, method for preparing same and pharmaceutical compositions containing same
09/14/2005CN1668587A Indole derivatives and drugs containing the same
09/14/2005CN1668585A 3, 6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists
09/14/2005CN1668579A Benzamide or phenylacetamide derivatives useful as thyroid receptor ligands
09/14/2005CN1668576A Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
09/14/2005CN1668561A Remedy
09/14/2005CN1668337A Agents for gene therapeutic for cerebrovascular disorders
09/14/2005CN1668336A Drug transport and delivery system
09/14/2005CN1668332A Liquid formulations with a high concentration of human growth hormone (HGH) comprising glycine
09/14/2005CN1668326A Intratumorally administered lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
09/14/2005CN1668325A Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
09/14/2005CN1668321A Use of ginkgo biloba extracts in order to promote muscle mass to the detriment of fatty mass
09/14/2005CN1668320A Tablet composition containing chinese orthodox medicine extract and process for producing the same
09/14/2005CN1668311A Method and composition for treating diabetes
09/14/2005CN1668306A 4-4(methylpiperazin-1-ylmethyl)-n-[4-methyl-3-((pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide for treating mutated-RET kinase associated diseases
09/14/2005CN1668301A Process for producing coated preparation
09/14/2005CN1668299A Methods for using JNK inhibitors for treating or preventing disease-related wasting
09/14/2005CN1668298A Antitumor compound and therapeutic uses thereof
09/14/2005CN1668297A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
09/14/2005CN1668296A Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
09/14/2005CN1668291A Substituted phenylsulfonamide inhibitors of beta amyloid production
09/14/2005CN1668286A Combination of an IBAT inhibitor and a metal salt for the treatment of diarrhea
1 ... 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 ... 1564